508 related articles for article (PubMed ID: 31573051)
1. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
2. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract][Full Text] [Related]
3. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
6. The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation.
Kang X; Li P; Zhang C; Zhao Y; Hu H; Wen G
Int J Oncol; 2020 Aug; 57(2):456-465. PubMed ID: 32468028
[TBL] [Abstract][Full Text] [Related]
7. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Jiang J; Li Y; Jiang Z
Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
9. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
Pan Y; Sun Y; Liu Z; Zhang C
Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
[TBL] [Abstract][Full Text] [Related]
10. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.
Liang H; Wang C; Gao K; Li J; Jia R
Mol Med Rep; 2019 Jul; 20(1):151-161. PubMed ID: 31115507
[TBL] [Abstract][Full Text] [Related]
11. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
Qian C; Liu Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
Li K; Yuan C
Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
[TBL] [Abstract][Full Text] [Related]
13. Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt/β-catenin signaling.
Li K; Mao S; Li X; Zhao H; Wang J; Wang C; Wu L; Zhang K; Yang H; Jin M; Zhou Z; Wang J; Huang G; Xie W
Cancer Sci; 2023 May; 114(5):2109-2122. PubMed ID: 36625184
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
15. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
[TBL] [Abstract][Full Text] [Related]
17. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA-125a-5p in lung cancer.
Gao Y; Zhang G; Liu J; Li H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760213
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
20. CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway.
Yao Y; Hua Q; Zhou Y; Shen H
Biomed Pharmacother; 2019 Mar; 111():1367-1375. PubMed ID: 30841451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
